Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics

Bone Marrow Transplant. 2020 Sep;55(9):1862-1864. doi: 10.1038/s41409-020-0832-6. Epub 2020 Feb 21.

C E Nath^{1

2}, J Trotman^{3

4}, I Nivison-Smith⁵, H Gurney^{3

6}, L Zeng⁷, P Presgrave^{8

9}, C Tiley¹⁰, D Joshua^{3

11}, I Kerridge¹², A J McLachlan³, P J Shaw^{7

3}

¹ The Children's Hospital at Westmead, Westmead, NSW, Australia. [email protected].
² University of Sydney, Sydney, NSW, Australia. [email protected].
³ University of Sydney, Sydney, NSW, Australia.
⁴ Concord Hospital, Concord, NSW, Australia.
⁵ Australasian Bone Marrow Transplant Recipient Registry, Darlinghurst, NSW, Australia.
⁶ Westmead Hospital, Westmead, NSW, Australia.
⁷ The Children's Hospital at Westmead, Westmead, NSW, Australia.
⁸ Wollongong Hospital, Wollongong, NSW, Australia.
⁹ University of Wollongong, Wollongong, NSW, Australia.
¹⁰ Gosford Hospital, Gosford, NSW, Australia.
¹¹ Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
¹² Royal North Shore Hospital, St Leonards, NSW, Australia.

No abstract available

Publication types